Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 22 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-4.85 Insider Own47.81% Shs Outstand10.62M Perf Week-3.35%
Market Cap70.51M Forward P/E- EPS next Y-0.74 Insider Trans0.00% Shs Float6.38M Perf Month26.26%
Income-64.82M PEG- EPS next Q-1.02 Inst Own11.34% Short Float1.72% Perf Quarter16.57%
Sales33.69M P/S2.09 EPS this Y-42.18% Inst Trans-15.36% Short Ratio0.85 Perf Half Y24.62%
Book/sh16.91 P/B0.34 EPS next Y79.39% ROA-19.70% Short Interest0.11M Perf Year-58.13%
Cash/sh5.95 P/C0.97 EPS next 5Y- ROE-25.15% 52W Range2.85 - 15.00 Perf YTD-2.37%
Dividend Est.- P/FCF- EPS past 5Y- ROI-31.28% 52W High-61.53% Beta-0.15
Dividend TTM- Quick Ratio2.08 Sales past 5Y-15.03% Gross Margin42.48% 52W Low102.46% ATR (14)0.47
Dividend Ex-DateNov 04, 2015 Current Ratio2.16 EPS Y/Y TTM87.07% Oper. Margin-159.69% RSI (14)57.99 Volatility2.84% 12.90%
Employees324 Debt/Eq0.01 Sales Y/Y TTM-81.66% Profit Margin-192.41% Recom1.00 Target Price9.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-1160.86% Payout- Rel Volume0.01 Prev Close5.87
Sales Surprise-27.62% EPS Surprise89.34% Sales Q/Q-89.62% EarningsApr 01 BMO Avg Volume129.29K Price5.77
SMA205.96% SMA5025.77% SMA2002.53% Trades Volume826 Change-1.70%
Date Action Analyst Rating Change Price Target Change
Jan-18-23Initiated Cantor Fitzgerald Overweight $7
Apr-01-24 01:53PM
Feb-09-24 09:25AM
Nov-20-23 06:00AM
Nov-01-23 06:00AM
07:10AM Loading…
Sep-15-23 07:10AM
Aug-29-23 12:46AM
Jun-30-23 08:00AM
Jun-26-23 09:30AM
Jun-25-23 08:45PM
Jun-05-23 07:20AM
Mar-14-23 08:56AM
Mar-02-23 07:00AM
Feb-02-23 04:01PM
Jan-19-23 05:00AM
10:00AM Loading…
Jan-17-23 10:00AM
Jan-10-23 08:05AM
Dec-16-22 06:27AM
Nov-30-22 09:15AM
Nov-10-22 08:00AM
Sep-09-22 11:17AM
Aug-12-22 09:34AM
Aug-08-22 04:45AM
Jul-16-22 08:03AM
Jun-08-22 12:56PM
Jun-06-22 09:55AM
May-23-22 12:00PM
May-19-22 12:15PM
May-18-22 06:30PM
11:00AM Loading…
May-17-22 11:00AM
Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the prevention, early detection, and treatment of diseases. It operates through the Prevention and Diagnostic segments. The Prevention segment is involved in the design and sale of genetics testing and stool-based DNA tests for early colorectal cancer screening. The Diagnostic segment consists of COVID-19 testing services and products, and precision oncology services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.